Charles River Laboratories Intl. Inc (N:CRL)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CRL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 22nd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 15/20 Sep 14/20 Massaro George Direct Ownership Common Stock S - Open market or private sale -70 $220.78
Sep 15/20 Sep 14/20 Massaro George Direct Ownership Common Stock S - Open market or private sale -1,288 $220.15
Sep 15/20 Sep 14/20 Massaro George Direct Ownership Common Stock S - Open market or private sale -585 $219.27
Aug 21/20 Aug 20/20 Girshick Birgit Direct Ownership Common Stock S - Open market or private sale -933 $213.51
Aug 19/20 Aug 18/20 Chubb Stephen D Direct Ownership Common Stock S - Open market or private sale -300 $218.58
Aug 19/20 Aug 18/20 Chubb Stephen D Direct Ownership Common Stock S - Open market or private sale -700 $217.25
Aug 19/20 Aug 18/20 Chubb Stephen D Direct Ownership Common Stock G - Gift -110  
Aug 19/20 Aug 17/20 Chubb Stephen D Direct Ownership Common Stock G - Gift -460  
Sep 15/20 Aug 7/20 Massaro George Direct Ownership Common Stock G - Gift -500  
Aug 11/20 Aug 7/20 Kochevar Deborah Turner Direct Ownership Common Stock S - Open market or private sale -2,319 $216.24
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CRL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 22nd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 15/20 Sep 14/20 Massaro George Direct Ownership Common Stock S - Open market or private sale -70 $220.78
Sep 15/20 Sep 14/20 Massaro George Direct Ownership Common Stock S - Open market or private sale -1,288 $220.15
Sep 15/20 Sep 14/20 Massaro George Direct Ownership Common Stock S - Open market or private sale -585 $219.27
Sep 15/20 Aug 7/20 Massaro George Direct Ownership Common Stock G - Gift -500  
Aug 21/20 Aug 20/20 Girshick Birgit Direct Ownership Common Stock S - Open market or private sale -933 $213.51
Aug 19/20 Aug 18/20 Chubb Stephen D Direct Ownership Common Stock S - Open market or private sale -300 $218.58
Aug 19/20 Aug 18/20 Chubb Stephen D Direct Ownership Common Stock S - Open market or private sale -700 $217.25
Aug 19/20 Aug 18/20 Chubb Stephen D Direct Ownership Common Stock G - Gift -110  
Aug 19/20 Aug 17/20 Chubb Stephen D Direct Ownership Common Stock G - Gift -460  
Aug 19/20 May 21/20 Chubb Stephen D Direct Ownership Common Stock G - Gift -155  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CRL

Competitors

Competitors with Recent Insider Filings
Moderna (OQ:MRNA)
Medpace Holdings (OQ:MEDP)
Forma Therapeutics Holdin (OQ:FMTX)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.